Hayes Anthony Acquires AIkido Pharma Inc. (AIKI) Shares

AIkido Pharma Inc. (NASDAQ:AIKI) finished Tuesday with an addition of $0.02 to close at $0.83, an upside of 3.49 percent. An average of 5,106,840 shares of common stock have been traded in the last five days. There was a gain of $0.0178 in the past week. The last 20 days have seen an average of 5,895,255 shares traded, while the 50-day average volume stands at 2,798,624.

AIKI stock has increased by 7.51% in the last month. The company shares reached their 1-month lowest point of $0.7210 on 09/20/21. With the stock rallying to its 52-week high on 02/16/21, shares of the company touched a low of $0.47 and a high of $2.55 in 52 weeks. In spite of this, the price is down -67.33% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Valuation Metrics

AIkido Pharma Inc. (AIKI) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 31.71 for the sector. This means investors are optimistic about the stock’s future prospects. In the last five years, AIkido Pharma Inc.’s PE ratio has ranged between 4.554 and 0.0635. The stock’s beta is 1.48. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.72.

The quick ratio of AIkido Pharma Inc. for the recent quarter was 97.00, and the current ratio was 97.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the recent quarter. Its gross profit as reported stood at $6.55 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, AIkido Pharma Inc.’s return on assets was -10.40%, compared to 18.0% over the last five years. Meanwhile, the return on equity (ROE) for the past 12 months has been -10.50% and the 5-year average holds at 41.6%. For the broader industry, ROE averaged -68.79 over the past year.

Technical Picture

From a technical analysis perspective, let’s take a brief look at AIkido Pharma Inc. (AIKI) price momentum. RSI 9-day as of the close on 05 October was 57.34%, suggesting the stock is Neutral, with historical volatility in this time frame at 83.38%.

As of today, AIKI’s price is $0.8172 +2.18% or $0.0178 from its 5-day moving average. AIKI is currently trading +9.62% higher than its 20-day SMA and -7.92% lower than its 100-day SMA. However, the stock’s current price level is -2.45% below the SMA50 and +34.37% above the SMA200.

The stochastic %K and %D were 38.82% and 38.86%, respectively, and the average true range (ATR) was 0.0655. With the 14-day stochastic at 47.46% and the average true range at 0.0604, the RSI (14) stands at 55.23%. The stock has reached -0.0121 on the 9-day MACD Oscillator while the 14-day reading was at 0.0138.

What is AIKI’s price target for the next 12 months?

Analysts predict a range of price targets between $1802.25 and $1802.25, with a median target of $1802.25. Taking a look at these predictions, the average price target given by analysts for AIkido Pharma Inc. (AIKI) stock is $1802.25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam